Skip to main content

Foresite Life Sciences Corp. (FSAC)

Foresite Life Sciences will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Market Cap319.50M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out31.95M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About FSAC

Foresite Life Sciences is a newly organized blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on our management team’s background and experience to identify promising opportunities in the biotechnology and life science infrastructure sectors. We believe that there is an especially favorable opportunity for investors in (i) preclinical to pre-commercial companies wi...

IndustryBlank Checks / SPAC
IPO DatePending
CEOJim Tananbaum
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolFSAC
Full Company Profile

News

Foresite Life Sciences IPO Registration Document (S-1)

Foresite Life Sciences Corp. has filed to go public with an IPO on the NASDAQ.

4 months ago - SEC